Yasushi Omuro

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of <i>HER2</i>-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study

Taroh Satoh, Rui‐Hua Xu, Hyun Cheol Chung et al. · Journal of Clinical Oncology · 2014 · 624 citations · Full text

Medicine, Oncology, Pharmacology +15

Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer

Hideki Ueno, Masafumi Ikeda, Makoto Ueno et al. · Cancer Chemotherapy and Pharmacology · 2016 · 158 citations

Medicine, Oncology, Pharmacology +15

Construction and validation of a practical prognostic index for patients with metastatic breast cancer.

Noboru Yamamoto, Toru Watanabe, Noriyuki Katsumata et al. · Journal of Clinical Oncology · 1998 · 143 citations

Medicine, Oncology, Chemotherapy +16

Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer

Yutaka Tokuda, Toru Watanabe, Yasushi Omuro et al. · British Journal of Cancer · 1999 · 113 citations · Full text

Pharmacy, Oncology, Pharmacology +17